Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Eric T. Wong, M.D.

TitleAssociate Professor of Neurology
InstitutionBeth Israel Deaconess Medical Center
DepartmentNeurology
AddressBeth Israel Deaconess Med Ctr
c/o Clifford Saper, KS-406
330 Brookline Ave
Boston MA 02215
Phone617/667-2622
Fax617/667-2987

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Chen WW, Balaj L, Liau LM, Samuels ML, Kotsopoulos SK, Maguire CA, Loguidice L, Soto H, Garrett M, Zhu LD, Sivaraman S, Chen C, Wong ET, Carter BS, Hochberg FH, Breakefield XO, Skog J. BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles. Mol Ther Nucleic Acids. 2013; 2:e109.
    View in: PubMed
  2. Zhu JJ, Wong ET. Personalized medicine for glioblastoma: current challenges and future opportunities. Curr Mol Med. 2013 Mar 1; 13(3):358-67.
    View in: PubMed
  3. Recht L, Mechtler LL, Wong ET, O'Connor PC, Rodda BE. Steroid-sparing effect of corticorelin acetate in peritumoral cerebral edema is associated with improvement in steroid-induced myopathy. J Clin Oncol. 2013 Mar 20; 31(9):1182-7.
    View in: PubMed
  4. Drappatz J, Brenner A, Wong ET, Eichler A, Schiff D, Groves MD, Mikkelsen T, Rosenfeld S, Sarantopoulos J, Meyers CA, Fielding RM, Elian K, Wang X, Lawrence B, Shing M, Kelsey S, Castaigne JP, Wen PY. Phase I study of GRN1005 in recurrent malignant glioma. Clin Cancer Res. 2013 Mar 15; 19(6):1567-76.
    View in: PubMed
  5. Floyd SR, Kasper EM, Uhlmann EJ, Fonkem E, Wong ET, Mahadevan A. Hypofractionated Radiotherapy and Stereotactic Boost with Concurrent and Adjuvant Temozolamide for Glioblastoma in Good Performance Status Elderly Patients - Early Results of a Phase II Trial. Front Oncol. 2012; 2:122.
    View in: PubMed
  6. Fonkem E, Uhlmann EJ, Floyd SR, Mahadevan A, Kasper E, Eton O, Wong ET. Melanoma brain metastasis: overview of current management and emerging targeted therapies. Expert Rev Neurother. 2012 Oct; 12(10):1207-15.
    View in: PubMed
  7. Yu A, Teich DL, Moonis G, Wong ET. Superior semicircular canal dehiscence in East Asian women with osteoporosis. BMC Ear Nose Throat Disord. 2012; 12(1):8.
    View in: PubMed
  8. Stupp R, Wong ET, Kanner AA, Steinberg D, Engelhard H, Heidecke V, Kirson ED, Taillibert S, Liebermann F, Dbalý V, Ram Z, Villano JL, Rainov N, Weinberg U, Schiff D, Kunschner L, Raizer J, Honnorat J, Sloan A, Malkin M, Landolfi JC, Payer F, Mehdorn M, Weil RJ, Pannullo SC, Westphal M, Smrcka M, Chin L, Kostron H, Hofer S, Bruce J, Cosgrove R, Paleologous N, Palti Y, Gutin PH. NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. Eur J Cancer. 2012 Sep; 48(14):2192-202.
    View in: PubMed
  9. Locasale JW, Melman T, Song S, Yang X, Swanson KD, Cantley LC, Wong ET, Asara JM. Metabolomics of human cerebrospinal fluid identifies signatures of malignant glioma. Mol Cell Proteomics. 2012 Jun; 11(6):M111.014688.
    View in: PubMed
  10. Fonkem E, Lun M, Wong ET. Rare phenomenon of extracranial metastasis of glioblastoma. J Clin Oncol. 2011 Dec 1; 29(34):4594-5.
    View in: PubMed
  11. Wang CC, Floyd SR, Chang CH, Warnke PC, Chio CC, Kasper EM, Mahadevan A, Wong ET, Chen CC. Cyberknife hypofractionated stereotactic radiosurgery (HSRS) of resection cavity after excision of large cerebral metastasis: efficacy and safety of an 800 cGy × 3 daily fractions regimen. J Neurooncol. 2012 Feb; 106(3):601-10.
    View in: PubMed
  12. Lun M, Lok E, Gautam S, Wu E, Wong ET. The natural history of extracranial metastasis from glioblastoma multiforme. J Neurooncol. 2011 Nov; 105(2):261-73.
    View in: PubMed
  13. Wong ET, Gautam S, Malchow C, Lun M, Pan E, Brem S. Bevacizumab for recurrent glioblastoma multiforme: a meta-analysis. J Natl Compr Canc Netw. 2011 Apr; 9(4):403-7.
    View in: PubMed
  14. Lehtinen MK, Zappaterra MW, Chen X, Yang YJ, Hill AD, Lun M, Maynard T, Gonzalez D, Kim S, Ye P, D'Ercole AJ, Wong ET, LaMantia AS, Walsh CA. The cerebrospinal fluid provides a proliferative niche for neural progenitor cells. Neuron. 2011 Mar 10; 69(5):893-905.
    View in: PubMed
  15. Jia Y, Kraus JA, Reddy H, Groff M, Wong ET. Polyradiculopathies from schwannomatosis. Open Neuroimag J. 2011; 5:9-13.
    View in: PubMed
  16. Sengupta S, Pedersen NP, Davis JE, Rojas R, Reddy H, Kasper E, Greenstein P, Wong ET. Illusion of stroke: intravascular lymphomatosis. Rev Neurol Dis. 2011; 8(3-4):e107-13.
    View in: PubMed
  17. Wong ET, Brem S. Taming glioblastoma by targeting angiogenesis: 3 years later. J Clin Oncol. 2011 Jan 10; 29(2):124-6.
    View in: PubMed
  18. Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, Degroot J, Wick W, Gilbert MR, Lassman AB, Tsien C, Mikkelsen T, Wong ET, Chamberlain MC, Stupp R, Lamborn KR, Vogelbaum MA, van den Bent MJ, Chang SM. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol. 2010 Apr 10; 28(11):1963-72.
    View in: PubMed
  19. Drappatz J, Norden AD, Wong ET, Doherty LM, Lafrankie DC, Ciampa A, Kesari S, Sceppa C, Gerard M, Phan P, Schiff D, Batchelor TT, Ligon KL, Young G, Muzikansky A, Weiss SE, Wen PY. Phase I study of vandetanib with radiotherapy and temozolomide for newly diagnosed glioblastoma. Int J Radiat Oncol Biol Phys. 2010 Sep 1; 78(1):85-90.
    View in: PubMed
  20. Wong ET, Barron L, Bloom J, Hackney D, Alsop D. Phase I study of metronomic temozolomide and arterial spin labeling perfusion measurements for recurrent glioblastoma multiforme. Neuro-Oncology. 2009.
  21. Swanson K, Lok E, Song S, Dessain J, Wong ET. Cerebrospinal fluid (CSF) biomarkers for breast cancer (BC) brain metastases. Annals of Neurology. 2009.
  22. Wong ET, Barron L, Bloom J, Hackney D, Alsop D. Arterial spin labeling (ASL) perfusion imaging for anti-angiogenic drug treatment of malignant gliomas. Sixth Annual World Congress for Brain Mapping and Image Guided Therapy. 2009; OP2.02.
  23. Park S, Zhao D, Hatanpaa KJ, Mickey BE, Saha D, Boothman DA, Story MD, Wong ET, Burma S, Georgescu MM, Rangnekar VM, Chauncey SS, Habib AA. RIP1 activates PI3K-Akt via a dual mechanism involving NF-kappaB-mediated inhibition of the mTOR-S6K-IRS1 negative feedback loop and down-regulation of PTEN. Cancer Res. 2009 May 15; 69(10):4107-11.
    View in: PubMed
  24. Swanson K, Lok E, Song S, Dessain J, Wong ET. Cerebrospinal fluid (CSF) biomarkers for breast cancer (BC) brain metastases. The Sixth Annual Symposium of the Dana –Farber/Harvard Cancer Center Program in Breast Cancer. 2009.
  25. Brem S, Wong ET. Angiogenesis and brain tumors: Molecular targets and molecular scalpels. Youman's Textbook of Neurosurgery. 2009; in press.
  26. Drappatz J, Norden AD, Wong ET, Doherty LM, LaFrankie DC, Ciampa A, Kesari S, Sceppa C, Gerard M, Phan P, Schiff D, Batchelor TT, Lassman A, Ligon KL, Young G, Muzikansky A, Weiss S, Wen PY. Phase I study of vandetanib with radiation therapy and temozolomide for newly-diagnosed glioblastoma. International Journal of Radiation Oncology Biology Physics. 2009; in press.
  27. Castaigne JP, Mikkelsen T, Schiff D, Wen P, Rosenfeld S, Groves M, Wong ET, Elian KM, Neale A, Lawrence B, Drappatz J. ANG1005 (Angiopep-2/paclitaxel conjugate) as a promising new drug therapy for patients with malignant glioma. Proceedings of the 100th Annual Meeting of the American Association for Cancer Research. 2009; Abstract 3781.
  28. Mechtler L, Wong ET, Hormigo A, Pannullo S, Hines V, Milsted R, O’Connor PC, Ryan RP, Recht L. A long-term open-label extension study examining the steroid-sparing effects of corticorelin acetate in patients with cerebral tumors. Proceed ASCO. 2009; 27:106s.
  29. Recht L, Mechtler L, Phuphanich S, Hormigo A, Hines V, Milstead R, O’Connor PC, Ryan RP, Wong ET. A placebo-controlled study investigating the dexamethasone sparing effects of corticorelin acetate in patients with cerebral tumors and peritumoral edema. Proceed ASCO. 2009; 27:106s.
  30. Drappatz J, Norden A, Wong ET, Doherty L, LaFrankie D, Lassman AB, Gerard M, Phan P, Schiff D, Wen PY. Phase I study of vandtanib with radiation therapy and temozolomide for newly-diagnosed glioblastoma. Proceed ASCO. 2009; 27:94s.
  31. Wong ET, Huberman M, Lu XQ, Mahadevan A. Bevacizumab reverses cerebral radiation necrosis. J Clin Oncol. 2008 Dec 1; 26(34):5649-50.
    View in: PubMed
  32. Drappatz J, Wong ET, Schiff D, Kesari S, Batchelor TT, Doherty L, Lafrankie DC, Ramakrishna N, Weiss S, Smith ST, Ciampa A, Zimmerman J, Ostrowsky L, David K, Norden A, Barron L, Sceppa C, Black PM, Wen PY. A pilot safety study of lenalidomide and radiotherapy for patients with newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2009 Jan 1; 73(1):222-7.
    View in: PubMed
  33. Wong ET, Brem S. Antiangiogenesis treatment for glioblastoma multiforme: challenges and opportunities. J Natl Compr Canc Netw. 2008 May; 6(5):515-22.
    View in: PubMed
  34. Lu XQ, Shanmugham LN, Mahadevan A, Nedea E, Stevenson MA, Kaplan I, Wong ET, La Rosa S, Wang F, Berman SM. Organ deformation and dose coverage in robotic respiratory-tracking radiotherapy. Int J Radiat Oncol Biol Phys. 2008 May 1; 71(1):281-9.
    View in: PubMed
  35. Chowdhary S, Wong ET. Bevacizumab combined with irinotecan for recurrent glioblastoma multiforme--improvement over available therapy? Nat Clin Pract Neurol. 2008 May; 4(5):242-3.
    View in: PubMed
  36. Wong ET, Alsop D, Lee D, Tam A, Barron L, Bloom J, Gautam S, Wu JK. Cerebrospinal fluid matrix metalloproteinase-9 increases during treatment of recurrent malignant gliomas. Cerebrospinal Fluid Res. 2008; 5:1.
    View in: PubMed
  37. Drappatz J, Wong ET, Schiff D, Kesari S, Batchelor TT, Ramakrishna N, Weiss S, Doherty L, LaFrankie D, Ciampa A, Smith ST, Zimmerman J, Ostrowsky L, David K, Norden A, Black P, Wen PY. A pilot study of lenalidomide and radiation therapy for patients with newly diagnosed glioblastoma multiforme. International Journal of Radiation Oncology Biology Physics. 2008; in press.
  38. Lu XQ, Shanmugham LN, Mahadevan A, Nedea E, Stevenson MA, Kaplan I, Wong ET, LaRosa S, Wang F, and Berman S. Organ deformation and dose coverage in robotic respiratory tracking treatment. International Journal of Radiation Oncology Biology Physics. 2008; 71(1):281-289.
  39. Wong ET, Huberman M, Lu XQ, Mahadevan A. Bevacizumab reverses cerebral radiation necrosis. Journal of Clinical Oncology. 2008; 26:5649-5650.
  40. Chowdhary S, Wong ET. Commentary: Bevacizumab plus irinotecan for recurrent glioblastoma multiforme. Nature Clinical Practice Neurology. 2008; 4:242-243.
  41. Yu M, Song S, Nguyen S, Jeyapalan S, Groves M, Swanson K, Gautam S, Wong ET. Vascular endothelial growth factor (VEGF) and matrix metalloprotease (MMP) cerebrospinal fluid (CSF) biomarkers in lymphomatous meningitis. Proceedings of the American Society of Clinical Oncologists. 2008.
  42. Wong ET, Brem S. Taming glioblastoma: targeting angiogenesis. J Clin Oncol. 2007 Oct 20; 25(30):4705-6.
    View in: PubMed
  43. Wong ET, Wu JK, Mahadevan A. Gefitinib and high-dose fractionated radiotherapy for carcinomatous encephalitis from non-small cell lung carcinoma. Biologics. 2007 Sep; 1(3):321-4.
    View in: PubMed
  44. Wong ET, Brem S. Editorial: Taming glioblastoma: Targeting angiogenesis. Journal of Clinical Oncology. 2007; 25:4795-4796.
  45. Recht L, Mechtler L, Alksne J, Arenson E, Paleologos N, Avgeropoulos N, Hormigo A, Perry J, Raizer J, Robins I, Wong E, Shulman M, Carr L. Long-term safety and steroid-sparing potential of corticorelin acetate injection for treatment of peritumoral brain edema: Third interim report of an open-label study as part of a phase III program. Neuro-Oncology. 2007; 9:570.
  46. Yu M, Song S, Nguyen S, Gu H, Wong ET. Cerebrospinal fluid (CSF) O6-methylguanine-methyltransferase (MGMT) from patients with glioblastoma multiforme. Neuro-Oncology. 2007; 9:549.
  47. Wong ET, Lee D, Tam A, Gautam S, Wu JK. Matrix metalloprotease-9 in cerebrospinal fluid correlates with disease activity in lymphomatous meningitis. Clin Lymphoma Myeloma. 2007 Jan; 7(4):305-8.
    View in: PubMed
  48. Wong ET, Linendoll N. Treatment advances for glioblastomas: tumor markers and targeted treatments. Applied Neurology. 2007; 3:18-22.
  49. Drappatz J, Wong ET, Kesari S, Batchelor T, Schiff D, Doherty L, Gigas D, Weiss S, Ramakrishna N, Black P, Ciampa A, Smith ST, Zimmerman J, Ostrowsky L, David K, Wen P. Pilot safety study of lenalidomide and radiation therapy in patients with newly diagnosed glioblastoma. Neurology. 2007; 68:A289.
  50. Yu M, Song S, Nguyen S, Jeyapalan S, Groves M, Swanson K, Gautam S, Wong ET. Vascular endothelial growth factor (VEGF) and matrix metalloprotease (MMP) cerebrospinal fluid (CSF) biomarkers in lymphomatous meningitis. Neuro-Oncology. 2007; 9:548.
  51. Recht L, Mechtler L, Alksne J, Arenson E, Paleologos N, Avgeropoulos N, Hormigo A, Perry J, Raizer J, Robins I, Wong E, Shulman M, Carr L. Long-term safety and steroid-sparing potential of corticorelin acetate injection for treatment of peritumoral brain edema: Third interim report of an open-label study as part of a phase III program. Neuro-Oncology. 2007; 9:570.
  52. Wong ET, Wu JK, Mahadevan A. Gefitinib and high-dose fractionated radiotherapy for carcinomatous encephalitis from non-small cell lung cancer. Biologics: Targets and Therapy. 2007; 1:321-324.
  53. Wong ET, Liu XQ, Devulapalli J, Mahadevan A. Cyberknife radiosurgery for basal skull plasmacytoma. Journal of Neuroimaging. 2006; 16(4):1-4.
  54. Wong ET, Lu XQ, Devulapalli J, Mahadevan A. Cyberknife radiosurgery for basal skull plasmacytoma. J Neuroimaging. 2006 Oct; 16(4):361-3.
    View in: PubMed
  55. Wong ET. Is protracted low-dose temozolomide feasible in glioma patients? Neurology. 2006 Aug 8; 67(3):543-4; author reply 543-4.
    View in: PubMed
  56. Ramnarain DB, Park S, Lee DY, Hatanpaa KJ, Scoggin SO, Otu H, Libermann TA, Raisanen JM, Ashfaq R, Wong ET, Wu J, Elliott R, Habib AA. Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells. Cancer Res. 2006 Jan 15; 66(2):867-74.
    View in: PubMed
  57. Mechtler L, Alksne J, Wong E, Arenson E, Recht L, Avgeropolous N, Eisenstat D, Hormigo A, Perry J, Raizer J, Shapiro W, Taylor L, Shulman M, Carr L. Interim report of the phase III open-label study of Xerecept (corticorelin acetate injection) for treatment of peritumoral brain edema in patients with primary or secondary brain tumors. Neuro-Oncology. 2006; 8:446-447.
  58. Glantz MJ, Chamberlain MC, Batchelor T, Wong E, Cavalli F, Shapiro WR. Interaction between route of intra-CSF chemotherapy administration and efficacy of therapy in patients with neoplastic meningitis. Proceedings of the American Society of Clinical Oncologists. 2006; 24:65s.
  59. Wong ET. Tumor growth, angiogenesis, and invasion. Journal of Neuro-Oncology. 2006; 77:295-296.
  60. Wong ET, Appignani B, Alsop D, Hackney D, Joseph J, Kasper E, Papavassiliou E. Perfusion-guided brain biopsy for gliomatosis cerebri. Eighth International Symposium on Anti-Angiogenic Agents. La Jolla, CA. 2006.
  61. Wong ET. Tumor growth, invasion, and angiogenesis in malignant gliomas. J Neurooncol. 2006 May; 77(3):295-6.
    View in: PubMed
  62. Wong ET. Management of central nervous system lymphomas using monoclonal antibodies: challenges and opportunities. Clin Cancer Res. 2005 Oct 1; 11(19 Pt 2):7151s-7157s.
    View in: PubMed
  63. Wong ET. Monoclonal antibody therapy for central nervous system lymphomas: an emerging treatment paradigm. Expert Opin Pharmacother. 2005 Jun; 6(7):1107-14.
    View in: PubMed
  64. Wong ET. Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide. Neurology. 2005 Mar 8; 64(5):934; author reply 934.
    View in: PubMed
  65. Wong ET, Alsop D, Appignani B, Mahadevan A, Lee D, Tam A, Barron L, Bloom J, Hackney D, Wu JK. Phase I study of irinotecan, thalidomide, and doxycycline combination for recurrent malignant gliomas, with correlative 3.0-Tesla arterial spin labeling perfusion imaging and cerebrospinal fluid zymography. Seventh International Symposium on Anit-Angiogenic Agents, La Jolla, CA. 2005.
  66. Appignani B, Alsop D, Hackney D, Wong E, Wu J. Arterial spin labeling perfusion imaging of brain tumors. Radiological Society of North America. 2005.
  67. Wong ET, Barron L, Wu JK. Peripartum pituitary hypertrophy. Neurology Reviews. 2005; 13:9-10.
  68. Wong ET, Appignani B, Wu JK, Mahadevan A, Joseph JJ, Lee D, Tam A, Bloom J, Barron L, Hackney D, Alsop D. Arterial spin labeling MRI detects early recurrence and anti-angiogenic drug effect in recurrent malignant gliomas. Proceedings of the American Society of Clinical Oncologists. 2005; 23:132s.
  69. Wong ET, Tishler R, Barron L, Wu JK. Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas. Cancer. 2004 Jul 1; 101(1):139-45.
    View in: PubMed
  70. Wong ET, Berkenblit A. The role of topotecan in the treatment of brain metastases. Oncologist. 2004; 9(1):68-79.
    View in: PubMed
  71. Wong ET. Neoplastic Meningitis. Cancer of the Nervous System, PM Black, JS Loeffler (Eds.). 2004; 683-689.
  72. Wong ET. Cranial Neuropathy. Clinical Practice of Hematology and Oncology:Presentation, Diagnosis, and Treatment. B Furie, RJ Mayer, Pa Cassileth, MG Atkins (Eds.). 2003; 27-31.
  73. Wong ET. The treatment of brain metastasis in the SCLC patient. In Current Perspective on the Treatment of Small Cell Lung Cancer. Oncology Journal Forum. 2003; 9:1-7.
  74. Wong ET. Headache. Clinical Practice of Hematology and Oncology:Presentation, Diagnosis, and Treatment. B Furie, RJ Mayer, Pa Cassileth, MG Atkins (Eds.). 2003; 19-22.
  75. Wong ET. Back Pain. Clinical Practice of Hematology and Oncology:Presentation, Diagnosis, and Treatment. B Furie, RJ Mayer, Pa Cassileth, MG Atkins (Eds.). 2003; 156-164.
  76. Jaeckle KA, Batchelor T, O'Day SJ, Phuphanich S, New P, Lesser G, Cohn A, Gilbert M, Aiken R, Heros D, Rogers L, Wong E, Fulton D, Gutheil JC, Baidas S, Kennedy JM, Mason W, Moots P, Russell C, Swinnen LJ, Howell SB. An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis. J Neurooncol. 2002 May; 57(3):231-9.
    View in: PubMed
  77. Friedberg MH, Wong ET, Wu JK. . Management of brain metastases in melanoma. UpToDate, Rose BD (Ed.). 2002.
  78. Wong ET, Joseph JJ, Tishler RK, Wu JK. Hemangioblastoma. UpToDate, Rose BD (Ed.). 2002.
  79. Chamberlain MC, Gilbert MR, Wong ET. Evaluation and treatment of neoplastic meningitis. 2001.
  80. Wong ET, Louis DT. Case Record of the Massachusetts General Hospital: A 61-year-old man with transient quadriplegia and apnea. New England Journal of Medicine. 2001; 344:832-839.
  81. Freedman SJ, Pantanowitz L, Joseph JJ, Wu J, Wong ET, Dezube BJ. Unusual locations for lymphomas. Case 2. Pineal lymphoma. Journal of Clinical Oncology. 2001; 19(11):2960-2963.
  82. Jaeckle KA, Phuphanich S, Bent MJ, Aiken R, Batchelor T, Campbell T, Fulton D, Gilbert M, Heros D, Rogers L, O'Day SJ, Akerley W, Allen J, Baidas S, Gertler SZ, Greenberg HS, LaFollette S, Lesser G, Mason W, Recht L, Wong E, Chamberlain MC, Cohn A, Glantz MJ, Gutheil JC, Maria B, Moots P, New P, Russell C, Shapiro W, Swinnen L, Howell SB. Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine. Br J Cancer. 2001 Jan; 84(2):157-63.
    View in: PubMed
  83. Wong ET, Wu JK, Hariharan S. Clinical presentation and diagnosis of brain tumors. UpToDate, Rose BD (Ed.). 2000.
  84. Wong ET, Joseph JJ. Meningeal carcinomatosis in lung cancer. Case 1. Carcinomatous leptomeningeal metastases. Journal of Clinical Oncology. 2000; 18(15):2926-2927.
  85. Hess KR, Wong ET, Jaeckle KA, Kyritsis AP, Levin VA, Prados MD, Yung WK. Response and progression in recurrent malignant glioma. Neuro Oncol. 1999 Oct; 1(4):282-8.
    View in: PubMed
  86. Wong ET, Hess KR, Gleason MJ, Jaeckle KA, Kyritsis AP, Prados MD, Levin VA, Yung WK. Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J Clin Oncol. 1999 Aug; 17(8):2572-8.
    View in: PubMed
  87. Wong ET. Recurrent cystic radiation necrosis of the brain. Oncol Rep. 1998 May-Jun; 5(3):685-7.
    View in: PubMed
  88. Wong ET, O'Brien S. Leptomeningeal disease in pre-leukemic syndrome: cytogenetic abnormality versus cellular morphology. Oncol Rep. 1998 Mar-Apr; 5(2):493-5.
    View in: PubMed
  89. Wong ET, Jackson EF, Hess KR, Schomer DF, Hazle JD, Kyritsis AP, Jaeckle KA, Yung WK, Levin VA, Leeds NE. Correlation between dynamic MRI and outcome in patients with malignant gliomas. Neurology. 1998 Mar; 50(3):777-81.
    View in: PubMed
  90. Hess KR, Wong ET, Yung WKA. Chemotherapy response criteria in malignant gliomas. Neurology. 1998; 50:1196-1998.
  91. Wong ET, Gunes S, Gaughan E, Patt RB, Ginsberg LE, Hassenbusch SJ, Payne R. Palliation of intractible cancer pain by MRI-guided cingulotomy. Clinical Journal of Pain. 1997; 13(3):260-263.
  92. Wong ET, Portlock CS, O'Brien JP, DeAngelis LM. Chemosensitive epidural spinal cord disease in non-Hodgkins lymphoma. Neurology. 1996 Jun; 46(6):1543-7.
    View in: PubMed
  93. Wong ET, Ginsberg LE, Patt RB, Payne R. Radiation insufficiency fracture of the sacrum may simulate metastatic prostate cancer. Primary Care & Cancer. 1996; 16:12-17.
  94. Wong ET, Malkin MG, Patt RB. Pain from a shunt-induced abdominal phlegmon in a cancer patient. Primary Care & Cancer. 1996; 17:22-27.
  95. Wong ET, Holstad SG, Mennerick SJ, Hong SE, Zorumski CF, Isenberg KE. Analysis of recombinant neuronal nicotinic acetylcholine receptors by transient expression in eucaryotic cells in vitro. Neuroscience Protocols. 1996; 20:1-11.
  96. Wong ET, Holstad SG, Mennerick SJ, Hong SE, Zorumski CF, Isenberg KE. Pharmacological and physiological properties of a putative ganglionic nicotinic receptor, alpha 3 beta 4, expressed in transfected eucaryotic cells. Brain Res Mol Brain Res. 1995 Jan; 28(1):101-9.
    View in: PubMed
  97. Vahdat L, Wong ET, Wile MJ, Rosenblum M, Foley KM, Warrell RP. Therapeutic and neurotoxic effects of 2-chlorodeoxyadenosine in adults with acute myeloid leukemia. Blood. 1994 Nov 15; 84(10):3429-34.
    View in: PubMed
  98. Wasserman AJ, Doillon CJ, Glasgold AI, Kato YP, Christiansen D, Rizvi A, Wong E, Goldstein J, Silver FH. Clinical application of scanning electron microscopy in analysis of collagenous biomaterials. Scanning Microscopy. 1988; 2:1635-1646.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Wong's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_